Image-Guided Radiotherapy: Has It Influenced Patient Outcomes?

Seminars in Radiation Oncology

Volumn 22, Issue 1, 2012, Pages 50-61

  Bujold, Alexis ^a   Craig, Tim ^b   Jaffray, David ^b   Dawson, Laura A ^b  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CONE BEAM COMPUTED TOMOGRAPHY; EVIDENCE BASED MEDICINE; GASTROINTESTINAL TOXICITY; HEAD AND NECK CANCER; HUMAN; IMAGE GUIDED RADIATION THERAPY; ONCOLOGY; OUTCOME ASSESSMENT; PATIENT POSITIONING; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIOSURGERY; RANDOM ERROR; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; SYSTEMATIC ERROR; TOTAL QUALITY MANAGEMENT;

HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; NEOPLASMS; RADIOLOGY, INTERVENTIONAL; RADIOTHERAPY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, COMPUTER-ASSISTED;

EID: 83455210526     PISSN: 10534296     EISSN: 15329461     Source Type: Journal    
DOI: 10.1016/j.semradonc.2011.09.001     Document Type: Review

References (161)

1. Knill C., Snyder M. An analysis of confidence limit calculations used in AAPM Task Group No. 119. Med Phys 2011, 38:1779-1784.
2. Gordon J.D., Krafft S.P., Jang S., et al. Confidence limit variation for a single IMRT system following the TG119 protocol. Med Phys 2011, 38:1641-1648.
3. Gérard K., Grandhaye J.-P., Marchesi V., et al. A comprehensive analysis of the IMRT dose delivery process using statistical process control (SPC). Med Phys 2009, 36:1275-1285.
4. Breen S.L., Moseley D.J., Zhang B., et al. Statistical process control for IMRT dosimetric verification. Med Phys 2008, 35:4417-4425.
5. Pawlicki T., Whitaker M., Boyer A.L. Statistical process control for radiotherapy quality assurance. Med Phys 2005, 32:2777-2786.
6. Pawlicki T., Mundt A.J. Quality in radiation oncology. Med Phys 2007, 34:1529-1534.
7. Bekelman J.E., Zelefsky M.J., Jang T.L., et al. Variation in adherence to external beam radiotherapy quality measures among elderly men with localized prostate cancer. Int J Radiat Oncol Biol Phys 2007, 69:1456-1466.
8. Huq M.S., Fraass B.A., Dunscombe P.B., et al. A method for evaluating quality assurance needs in radiation therapy. Int J Radiat Oncol Biol Phys 2008, 71(suppl):S170-S173.
9. Rath F. Tools for developing a quality management program: Proactive tools (process mapping, value stream mapping, fault tree analysis, and failure mode and effects analysis). Int J Radiat Oncol Biol Phys 2008, 71(suppl):S187-S190.
10. Caldwell B.S. Tools for developing a quality management program: Human factors and systems engineering tools. Int J Radiat Oncol Biol Phys 2008, 71(suppl):S191-S194.
11. Silvey A.B., Warrick L.H. Linking quality assurance to performance improvement to produce a high reliability organization. Int J Radiat Oncol Biol Phys 2008, 71(1 suppl):S195-S199. (suppl).
12. Pawlicki T., Whitaker M. Variation and control of process behavior. Int J Radiat Oncol Biol Phys 2008, 71(suppl):S210-S214.
13. Marks L.B., Jackson M., Xie L. The challenge of maximizing safety in radiation oncology. Pract. Radiol Oncol 2011, 1:2-14.
14. Hendee W.R., Herman M.G. Improving patient safety in radiation oncology. Pract. Radiol Oncol 2011, 1:16-21.
15. Bissonnette J.-P., Moseley D.J., Jaffray D.A. A quality assurance program for image quality of cone-beam CT guidance in radiation therapy. Med Phys 2008, 35:1807-1815.
16. Yin F.F., Wong J., Balter J. The role of in-room kV x-ray imaging for patient setup and target localization 2009, in Report of Task Group (ed):The Therapy Imaging Committee, American Association of Physicists in Medicine, College Park, MD.
17. Klein E.E., Hanley J., Bayouth J., et al. Task Group 142 report: Quality assurance of medical accelerators. Med Phys 2009, 36:4197-4212.
18. Williamson J.F., Dunscombe P.B., Sharpe M.B., et al. Quality assurance needs for modern image-based radiotherapy: Recommendations from 2007 interorganizational symposium on "quality assurance of radiation therapy: Challenges of advanced technology". Int J Radiat Oncol Biol Phys 2008, 71(suppl):S2-S12.
19. Bissonnette J.P., Medlam G. Trend analysis of radiation therapy incidents over seven years. Radiother Oncol 2010, 96:139-144.
20. Bel A., van Herk M., Bartelink H., et al. A verification procedure to improve patient set-up accuracy using portal images. Radiother Oncol 1993, 29:253-260.
21. de Boer H.C., Heijmen B.J. A protocol for the reduction of systematic patient setup errors with minimal portal imaging workload. Int J Radiat Oncol Biol Phys 2001, 50:1350-1365.
22. Yan D., Wong J., Vicini F., et al. Adaptive modification of treatment planning to minimize the deleterious effects of treatment setup errors. Int J Radiat Oncol Biol Phys 1997, 38:197-206.
23. Yan D., Ziaja E., Jaffray D., et al. The use of adaptive radiation therapy to reduce setup error: A prospective clinical study. Int J Radiat Oncol Biol Phys 1998, 41:715-720.
24. Yan D., Lockman D., Brabbins D., et al. An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer. Int J Radiat Oncol Biol Phys 2000, 48:289-302.
25. Bissonnette J.P., Purdie T.G., Higgins J.A., et al. Cone-beam computed tomographic image guidance for lung cancer radiation therapy. Int J Radiat Oncol Biol Phys 2009, 73:927-934.
26. Li W., Moseley D.J., Bissonnette J.P., et al. Setup reproducibility for thoracic and upper gastrointestinal radiation therapy: Influence of immobilization method and on-line cone-beam CT guidance. Med Dosim 2010, 35:287-296.
27. Chung P.W., Haycocks T., Brown T., et al. On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 2004, 60:329-334.
28. Zeidan O.A., Langen K.M., Meeks S.L., et al. Evaluation of image-guidance protocols in the treatment of head and neck cancers. Int J Radiat Oncol Biol Phys 2007, 67:670-677.
29. Hawkins M.A., Brock K.K., Eccles C., et al. Assessment of residual error in liver position using kV cone-beam computed tomography for liver cancer high-precision radiation therapy. Int J Radiat Oncol Biol Phys 2006, 66:610-619.
30. Meyer J., Wilbert J., Baier K., et al. Positioning accuracy of cone-beam computed tomography in combination with a HexaPOD robot treatment table. Int J Radiat Oncol Biol Phys 2007, 67:1220-1228.
31. Kupelian P.A., Lee C., Langen K.M., et al. Evaluation of image-guidance strategies in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70:1151-1157.
32. Guckenberger M., Meyer J., Wilbert J., et al. Intra-fractional uncertainties in cone-beam CT based image-guided radiotherapy (IGRT) of pulmonary tumors. Radiother Oncol 2007, 83:57-64.
33. Sandhu A., Sethi R., Rice R., et al. Prostate bed localization with image-guided approach using on-board imaging: Reporting acute toxicity and implications for radiation therapy planning following prostatectomy. Radiother Oncol 2008, 88:20-25.
34. Sonke J.J., Rossi M., Wolthaus J., et al. Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance. Int J Radiat Oncol Biol Phys 2009, 74:567-574.
35. Craig T., Moiseenko V., Battista J., et al. The impact of geometric uncertainty on hypofractionated external beam radiation therapy of prostate cancer. Int J Radiat Oncol Biol Phys 2003, 57:833-842.
36. Chetty I.J., Rosu M., Tyagi N., et al. A fluence convolution method to account for respiratory motion in three-dimensional dose calculations of the liver: A Monte Carlo study. Med Phys 2003, 30:1776-1780.
37. Song W.Y., Schaly B., Bauman G., et al. Evaluation of image-guided radiation therapy (IGRT) technologies and their impact on the outcomes of hypofractionated prostate cancer treatments: A radiobiologic analysis. Int J Radiat Oncol Biol Phys 2006, 64:289-300.
38. van Haaren P.M., Bel A., Hofman P., et al. Influence of daily setup measurements and corrections on the estimated delivered dose during IMRT treatment of prostate cancer patients. Radiother Oncol 2009, 90:291-298.
39. Velec M., Moseley J.L., Eccles C.L., et al. Effect of breathing motion on radiotherapy dose accumulation in the abdomen using deformable registration. Int J Radiat Oncol Biol Phys 2011, 80:265-272.
40. Stroom J.C., de Boer H.C., Huizenga H., et al. Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability. Int J Radiat Oncol Biol Phys 1999, 43:905-919.
41. van Herk M., Remeijer P., Rasch C., et al. The probability of correct target dosage: Dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 2000, 47:1121-1135.
42. van Herk M., Remeijer P., Lebesque J.V. Inclusion of geometric uncertainties in treatment plan evaluation. Int J Radiat Oncol Biol Phys 2002, 52:1407-1422.
43. Islam M.K., Purdie T.G., Norrlinger B.D., et al. Patient dose from kilovoltage cone beam computed tomography imaging in radiation therapy. Med Phys 2006, 33:1573-1582.
44. Walter C., Boda-Heggemann J., Wertz H., et al. Phantom and in-vivo measurements of dose exposure by image-guided radiotherapy (IGRT): MV portal images vs. kV portal images vs. cone-beam CT. Radiother Oncol 2007, 85:418-423.
45. Ding G.X., Coffey C.W. Radiation dose from kilovoltage cone beam computed tomography in an image-guided radiotherapy procedure. Int J Radiat Oncol Biol Phys 2009, 73:610-617.
46. Simon J., Eschwege F., El Hajj L. Epinal #2: 409 Patients Overexposed during Radiotherapy for Prostate Cancer after Daily Use of Portal Imaging Controls. Proc Am Soc Ther Radiat Oncol 2010, 78:S361. (abstr).
47. Andrews D.W., Scott C.B., Sperduto P.W., et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363:1665-1672.
48. Kondziolka D., Patel A., Lunsford L.D., et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999, 45:427-434.
49. Nataf F., Schlienger M., Liu Z., et al. Radiosurgery with or without a 2-mm margin for 93 single brain metastases. Int J Radiat Oncol Biol Phys 2008, 70:766-772.
50. Noël G., Simon J.M., Valery C.A., et al. Radiosurgery for brain metastasis: Impact of CTV on local control. Radiother Oncol 2003, 68:15-21.
51. Shaw E., Scott C., Souhami L., et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000, 47:291-298.
52. Ramakrishna N., Rosca F., Friesen S., et al. A clinical comparison of patient setup and intra-fraction motion using frame-based radiosurgery versus a frameless image-guided radiosurgery system for intracranial lesions. Radiother Oncol 2010, 95:109-115.
53. Chen J.C., Bugoci D.M., Girvigian M.R. Control of brain metastases using frameless image-guided radiosurgery. Neurosurg Focus 2009, 27:E6.
54. Masi L., Casamassima F., Polli C., et al. Cone beam CT image guidance for intracranial stereotactic treatments: Comparison with a frame guided set-up. Int J Radiat Oncol Biol Phys 2008, 71:926-933.
55. Murphy M.J. Intrafraction geometric uncertainties in frameless image-guided radiosurgery. Int J Radiat Oncol Biol Phys 2009, 73:1364-1368.
56. Tryggestad E., Christian M., Ford E. Inter- and intrafraction patient positioning uncertainties for intracranial radiotherapy: A study of four frameless, thermoplastic mask-based immobilization strategies using daily cone-beam CT. Int J Radiat Oncol Biol Phys 2011, 80:281-290.
57. Minniti G., Amichetti M., Enrici R.M. Radiotherapy and radiosurgery for benign skull base meningiomas. Radiol Oncol 2009, 4:42.
58. Oldfield E.H. Editorial: Unresolved issues: Radiosurgery versus radiation therapy; medical suppression of growth hormone production during radiosurgery; and endoscopic surgery versus microscopic surgery. Neurosurg Focus 2010, 29:E16.
59. Kim S., Jin H., Yang H., et al. A study on target positioning error and its impact on dose variation in image-guided stereotactic body radiotherapy for the spine. Int J Radiat Oncol Biol Phys 2009, 73:1574-1579.
60. Fürweger C., Drexler C., Kufeld M., et al. Patient motion and targeting accuracy in robotic spinal radiosurgery: 260 single-fraction fiducial-free cases. Int J Radiat Oncol Biol Phys 2010, 78:937-945.
61. Wang H., Shiu A., Wang C., et al. Dosimetric effect of translational and rotational errors for patients undergoing image-guided stereotactic body radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys 2008, 71:1261-1271.
62. Chang E.L., Shiu A.S., Mendel E., et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 2007, 7:151-160.
63. Sahgal A., Bilsky M., Chang E.L., et al. Stereotactic body radiotherapy for spinal metastases: Current status, with a focus on its application in the postoperative patient. J Neurosurg Spine 2011, 14:151-166.
64. Sahgal A., Larson D.A., Chang E.L. Stereotactic body radiosurgery for spinal metastases: A critical review. Int J Radiat Oncol Biol Phys 2008, 71:652-665.
65. Calcerrada Díaz-Santos N., Blasco Amaro J.A., Cardiel G.A., et al. The safety and efficacy of robotic image-guided radiosurgery system treatment for intra- and extracranial lesions: A systematic review of the literature. Radiother Oncol 2008, 89:245-253.
66. Sahgal A., Ma L., Gibbs I., et al. Spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2010, 77:548-553.
67. Mahadevan A, Floyd S, Wong E: Stereotactic body radiotherapy reirradiation for recurrent epidural spinal metastases. Int J Radiat Oncol Biol Phys (in press).
68. Chi A., Liao Z., Nguyen N.P., et al. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications. Radiother Oncol 2010, 94:1-11.
69. Yeung A.R., Li J.G., Shi W., et al. Tumor localization using cone-beam CT reduces setup margins in conventionally fractionated radiotherapy for lung tumors. Int J Radiat Oncol Biol Phys 2009, 74:1100-1107.
70. Grills I.S., Hugo G., Kestin L.L., et al. Image-guided radiotherapy via daily online cone-beam CT substantially reduces margin requirements for stereotactic lung radiotherapy. Int J Radiat Oncol Biol Phys 2008, 70:1045-1056.
71. Purdie T.G., Bissonnette J.P., Franks K., et al. Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: Localization, verification, and intrafraction tumor position. Int J Radiat Oncol Biol Phys 2007, 68:243-252.
72. Keall P.J., Mageras G.S., Balter J.M. The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys 2006, 33:3874-3900.
73. Chetty I.J., Rosu M., McShan D.L., et al. Accounting for center-of-mass target motion using convolution methods in Monte Carlo-based dose calculations of the lung. Med Phys 2004, 31:925-932.
74. Bortfeld T., Jiang S.B., Rietzel E. Effects of motion on the total dose distribution. Semin Radiat Oncol 2004, 14:41-51.
75. Wunderink W., Méndez Romero A., Vásquez Osorio E.M., et al. Target coverage in image-guided stereotactic body radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys 2007, 68:282-290.
76. Chang D.T., Swaminath A., Kozak M. Stereotactic body radiotherapy for colorectal liver metastases. Cancer 2011, 117:4060-4069.
77. Guckenberger M., Baier K., Polat B., et al. Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy. Radiother Oncol 2010, 97:65-70.
78. Marks L.B., Bentzen S.M., Deasy J.O., et al. Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys 2010, 76(suppl):S70-S76.
79. Pan C.C., Kavanagh B.D., Dawson L.A., et al. Radiation-associated liver injury. Int J Radiat Oncol Biol Phys 2010, 76(suppl):S94-S100.
80. Kavanagh B.D., Pan C.C., Dawson L.A., et al. Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys 2010, 76(suppl):S101-S107.
81. Bissonnette J.P., Franks K.N., Purdie T.G., et al. Quantifying interfraction and intrafraction tumor motion in lung stereotactic body radiotherapy using respiration-correlated cone beam computed tomography. Int J Radiat Oncol Biol Phys 2009, 75:688-695.
82. Case R.B., Sonke J.J., Moseley D.J., et al. Inter- and intrafraction variability in liver position in non-breath-hold stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2009, 75:302-308.
83. Dawson L.A., Balter J.M. Interventions to reduce organ motion effects in radiation delivery. Semin Radiat Oncol 2004, 14:76-80.
84. Fuss M., Salter B.J., Cavanaugh S.X., et al. Daily ultrasound-based image-guided targeting for radiotherapy of upper abdominal malignancies. Int J Radiat Oncol Biol Phys 2004, 59:1245-1256.
85. Galerani A.P., Grills I., Hugo G., et al. Dosimetric impact of online correction via cone-beam CT-based image guidance for stereotactic lung radiotherapy. Int J Radiat Oncol Biol Phys 2010, 78:1571-1578.
86. Ikushima H., Balter P., Komaki R., et al. Daily alignment results of in-room computed tomography-guided stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 2011, 79:473-480.
87. Masi L., Casamassima F., Menichelli C., et al. On-line image guidance for frameless stereotactic radiotherapy of lung malignancies by cone beam CT: Comparison between target localization and alignment on bony anatomy. Acta Oncol 2008, 47:1422-1431.
88. Shirato H., Seppenwoolde Y., Kitamura K., et al. Intrafractional tumor motion: Lung and liver. Semin Radiat Oncol 2004, 14:10-18.
89. Verellen D., Depuydt T., Gevaert T., et al. Gating and tracking, 4D in thoracic tumours. Cancer Radiother 2010, 14:446-454.
90. Verellen D., Tournel K., Van de Steene J. Breathing-synchronized irradiation using stereoscopic kV-imaging to limit influence of interplay between leaf motion and organ motion in 3D-CRT and IMRT: Dosimetric verification and first clinical experience. Int J Radiat Oncol Biol Phys 2006, 66(suppl 1):S108-S119.
91. Chang J.Y., Dong L., Liu H., et al. Image-guided radiation therapy for non-small cell lung cancer. J Thorac Oncol 2008, 3:177-186.
92. Bentzen S.M. High-tech in radiation oncology: Should there be a ceiling?. Int J Radiat Oncol Biol Phys 2004, 58:320-330.
93. Cahlon O., Hunt M., Zelefsky M.J. Intensity-modulated radiation therapy: Supportive data for prostate cancer. Semin Radiat Oncol 2008, 18:48-57.
94. Kupelian P.A., Langen K.M., Willoughby T.R., et al. Image-Guided Radiotherapy for Localized Prostate Cancer: Treating a Moving Target. Semin Radiat Oncol 2008, 18:58-66.
95. Latorzeff I., Mazurier J., Boutry C., et al. Apports de la radiothérapie avec modulation d'intensité guidée par l'image dans les cancers prostatiques. Cancer Radiothérapie 2010, 14:479-487.
96. de Crevoisier R., Tucker S.L., Dong L., et al. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2005, 62:965-973.
97. Heemsbergen W.D., Hoogeman M.S., Witte M.G., et al. Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: Results from the Dutch trial of 68 GY versus 78 Gy. Int J Radiat Oncol Biol Phys 2007, 67:1418-1424.
98. Kupelian P.A., Willoughby T.R., Reddy C.A., et al. Impact of image guidance on outcomes after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70:1146-1150.
99. Engels B., Tournel K., Soete G., et al. Assessment of rectal distention in radiotherapy of prostate cancer using daily megavoltage CT image guidance. Radiother Oncol 2009, 90:377-381.
100. Litzenberg D.W., Balter J.M., Hadley S.W., et al. Influence of intrafraction motion on margins for prostate radiotherapy. Int J Radiat Oncol Biol Phys 2006, 65:548-553.
101. Brabbins D., Martinez A., Yan D., et al. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: Analysis of chronic toxicity. Int J Radiat Oncol Biol Phys 2005, 61:400-408.
102. Ghilezan M., Yan D., Liang J., et al. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect?. A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery. Int J Radiat Oncol Biol Phys 2004, 60:1602-1610.
103. Landoni V., Saracino B., Marzi S., et al. A study of the effect of setup errors and organ motion on prostate cancer treatment with IMRT. Int J Radiat Oncol Biol Phys 2006, 65:587-594.
104. Langen K.M., Zhang Y., Andrews R.D., et al. Initial experience with megavoltage (MV) CT guidance for daily prostate alignments. Int J Radiat Oncol Biol Phys 2005, 62:1517-1524.
105. Martinez A.A., Yan D., Lockman D., et al. Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer. Int J Radiat Oncol Biol Phys 2001, 50:1226-1234.
106. Redpath A.T., Wright P., Muren L.P. The contribution of on-line correction for rotational organ motion in image-guided radiotherapy of the bladder and prostate. Acta Oncol 2008, 47:1367-1372.
107. Rijkhorst E.J., Lakeman A., Nijkamp J., et al. Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: Prostate, rectum, and bladder dose effects. Int J Radiat Oncol Biol Phys 2009, 75:1254-1260.
108. Serago C.F., Buskirk S.J., Igel T.C., et al. Comparison of daily megavoltage electronic portal imaging or kilovoltage imaging with marker seeds to ultrasound imaging or skin marks for prostate localization and treatment positioning in patients with prostate cancer. Int J Radiat Oncol Biol Phys 2006, 65:1585-1592.
109. Scarbrough T.J., Golden N.M., Ting J.Y., et al. Comparison of ultrasound and implanted seed marker prostate localization methods: Implications for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2006, 65:378-387.
110. Vargas C., Martinez A., Kestin L.L., et al. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2005, 62:1297-1308.
111. Wong J.R., Gao Z., Merrick S., et al. Potential for higher treatment failure in obese patients: Correlation of elevated body mass index and increased daily prostate deviations from the radiation beam isocenters in an analysis of 1,465 computed tomographic images. Int J Radiat Oncol Biol Phys 2009, 75:49-55.
112. Ost P., De Gersem W., De Potter B. A comparison of the acute toxicity profile between two-dimensional and three-dimensional image-guided radiotherapy for postoperative prostate cancer. Clin Oncol R Coll Radiol 2011, 23:344-349.
113. Chung H.T., Xia P., Chan L.W., et al. Does image-guided radiotherapy improve toxicity profile in whole pelvic-treated high-risk prostate cancer?. Comparison between IG-IMRT and IMRT. Int J Radiat Oncol Biol Phys 2009, 73:53-60.
114. Beltran C., Herman M.G., Davis B.J. Planning target margin calculations for prostate radiotherapy based on intrafraction and interfraction motion using four localization methods. Int J Radiat Oncol Biol Phys 2008, 70:289-295.
115. Schallenkamp J.M., Herman M.G., Kruse J.J., et al. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int J Radiat Oncol Biol Phys 2005, 63:800-811.
116. Tuohy Y., George S., Maher M. Analysis of setup accuracy of prostate patients comparing implanted fiducial markers to pelvic bony anatomy. Int J Radiat Oncol Biol Phys 2009, 75(suppl 1). S633-S633.
117. Strom S.S., Kamat A.M., Gruschkus S.K., et al. Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer 2006, 107:631-639.
118. Mageras G.S., Mechalakos J. Planning in the IGRT context: Closing the loop. Semin Radiat Oncol 2007, 17:268-277.
119. Gelinas M., Fletcher G.H. Incidence and causes of local failure of irradiation in squamous cell carcinoma of the faucial arch, tonsillar fossa and base of the tongue. Radiology 1973, 108:383-387.
120. Fletcher G.H., Hamberger A.D. Causes of failure in irradiation of squamous-cell carcinoma of the supraglottic larynx. Radiology 1974, 111:697-700.
121. Niederer J., Hawkins N.V., Rider W.D., et al. Failure analysis of radical radiation therapy of supraglottic laryngeal carcinoma. Int J Radiat Oncol Biol Phys 1977, 2:621-629.
122. Byhardt R.W., Cox J.D., Hornburg A., et al. Weekly localization films and detection of field placement errors. Int J Radiat Oncol Biol Phys 1978, 4:881-887.
123. Herman M.G. Clinical use of electronic portal imaging. Semin Radiat Oncol 2005, 15:157-167.
124. Den R.B., Doemer A., Kubicek G., et al. Daily image guidance with cone-beam computed tomography for head-and-neck cancer intensity-modulated radiotherapy: A prospective study. Int J Radiat Oncol Biol Phys 2010, 76:1353-1359.
125. Nath S.K., Simpson D.R., Rose B.S. Recent advances in image-guided radiotherapy for head and neck carcinoma. J Oncol 2009, 2009:1-10.
126. Giske K., Stoiber E.M., Schwarz M. Local setup errors in image-guided radiotherapy for head and neck cancer patients immobilized with a custom-made device. Int J Radiat Oncol Biol Phys 2011, 80:582-589.
127. Li H., Zhu X.R., Zhang L., et al. Comparison of 2D radiographic images and 3D cone beam computed tomography for positioning head-and-neck radiotherapy patients. Int J Radiat Oncol Biol Phys 2008, 71:916-925.
128. van Kranen S., van Beek S., Rasch C., et al. Setup uncertainties of anatomical sub-regions in head-and-neck cancer patients after offline CBCT guidance. Int J Radiat Oncol Biol Phys 2009, 73:1566-1573.
129. Chen AM, Farwell DG, Luu Q: Evaluation of the planning target volume in the treatment of head and neck cancer with intensity-modulated radiotherapy: What is the appropriate expansion margin in the setting of daily image guidance? Int J Radiat Oncol Biol Phys (in press).
130. Wang J., Bai S., Chen N., et al. The clinical feasibility and effect of online cone beam computer tomography-guided intensity-modulated radiotherapy for nasopharyngeal cancer. Radiother Oncol 2009, 90:221-227.
131. Duma M.N., Kampfer S., Wilkens J.J., et al. Comparative analysis of an image-guided versus a non-image-guided setup approach in terms of delivered dose to the parotid glands in head-and-neck cancer IMRT. Int J Radiat Oncol Biol Phys 2010, 77:1266-1273.
132. Velec M., Waldron J.N., O'Sullivan B., et al. Cone-beam CT assessment of interfraction and intrafraction setup error of two head-and-neck cancer thermoplastic masks. Int J Radiat Oncol Biol Phys 2010, 76:949-955.
133. Sharpe M.B., Brock K.K., Rehbinder H. Adaptive planning and delivery to account for anatomical changes induced by radiation therapy of head and neck cancer. Proc Am Soc Ther Radiat Oncol 2005, 63:S3. (abstr).
134. Mohan R., Zhang X., Wang H., et al. Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes. Int J Radiat Oncol Biol Phys 2005, 61:1258-1266.
135. O'Daniel J.C., Garden A.S., Schwartz D.L., et al. Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: Is what you plan what you get?. Int J Radiat Oncol Biol Phys 2007, 69:1290-1296.
136. Kinzie J.J., Hanks G.E., MacLean C.J., et al. Patterns of care study: Hodgkin's disease relapse rates and adequacy of portals. Cancer 1983, 52:2223-2226.
137. Holupka E.J., Humm J.L., Tarbell N.J., et al. Effect of set-up error on the dose across the junction of matching cranial-spinal fields in the treatment of medulloblastoma. Int J Radiat Oncol Biol Phys 1993, 27:345-352.
138. Nijkamp J., de Jong R., Sonke J.J., et al. Target volume shape variation during hypo-fractionated preoperative irradiation of rectal cancer patients. Radiother Oncol 2009, 92:202-209.
139. Borst G.R., Sonke J.J., Betgen A., et al. Kilo-voltage cone-beam computed tomography setup measurements for lung cancer patients; first clinical results and comparison with electronic portal-imaging device. Int J Radiat Oncol Biol Phys 2007, 68:555-561.
140. Viswanathan A.N., Erickson B.A. Three-dimensional imaging in gynecologic brachytherapy: A survey of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys 2010, 76:104-109.
141. Zelefsky M.J., Yamada Y., Cohen G.N., et al. Intraoperative real-time planned conformal prostate brachytherapy: Post-implantation dosimetric outcome and clinical implications. Radiother Oncol 2007, 84:185-189.
142. Shah J.N., Wuu C.S., Katz A.E., et al. Improved biochemical control and clinical disease-free survival with intraoperative versus preoperative preplanning for transperineal interstitial permanent prostate brachytherapy. Cancer J 2006, 12:289-297.
143. Beaulieu L., Evans D.A., Aubin S., et al. Bypassing the learning curve in permanent seed implants using state-of-the-art technology. Int J Radiat Oncol Biol Phys 2007, 67:71-77.
144. Foster W., Beaulieu L., Harel F., et al. [The impact of 3D image guided prostate brachytherapy on therapeutic ratio: the Quebec University Hospital experience]. Cancer Radiother 2007, 11:452-460.
145. Polo A., Salembier C., Venselaar J., et al. Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy. Radiother Oncol 2010, 94:12-23.
146. Dawson L.A., Ménard C. Imaging in radiation oncology: A perspective. Oncologist 2010, 15:338-349.
147. Boukaram C., Hannoun-Levi J.-M. Management of prostate cancer recurrence after definitive radiation therapy. Cancer Treat Rev 2010, 36:91-100.
148. Davidson M.T., Yuen J., D'Souza D.P., et al. Optimization of high-dose-rate cervix brachytherapy applicator placement: The benefits of intraoperative ultrasound guidance. Brachytherapy 2008, 7:248-253.
149. Georg P., Lang S., Dimopoulos J.C., et al. Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 2011, 79:356-362.
150. Georg P., Kirisits C., Goldner G., et al. Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. Radiother Oncol 2009, 91:173-180.
151. Potter R., Kirisits C., Fidarova E.F., et al. Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma. Acta Oncol 2008, 47:1325-1336.
152. Tanderup K., Nielsen S.K., Nyvang G.B., et al. From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer. Radiother Oncol 2010, 94:173-180.
153. Tan L.T., Coles C.E., Hart C., et al. Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator-The Addenbrooke's experience. Clin Oncol R Coll Radiol 2009, 21:175-182.
154. Dimopoulos J.C., Pötter R., Lang S., et al. Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. Radiother Oncol 2009, 93:311-315.
155. Dimopoulos J.C., De Vos V., Berger D., et al. Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: Application of the GYN GEC-ESTRO recommendations. Radiother Oncol 2009, 91:166-172.
156. Potter R., Haie-Meder C., Van Limbergen E. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006, 78:67-77.
157. Van Herk M. Will IGRT live up to its promise?. Acta Oncol 2008, 47:1186-1187.
158. Murphy M.J., Balter J., Balter S. The management of imaging dose during image-guided radiotherapy: Report of the AAPM Task Group 75. Med Phys 2007, 34:4041-4063.
159. Delpon G., Llagostera C., Le Blanc M., et al. [Use of IGRT for prostate cancers (OBI-CBCT Varian, ExacTrac BrainLAB and MVCT TomoTherapy)]. Cancer Radiother 2009, 13:399-407.
160. Peng C., Kainz K., Lawton C., et al. A comparison of daily megavoltage CT and ultrasound image guided radiation therapy for prostate cancer. Med Phys 2008, 35:5619-5628.
161. Cheng C.W., Wong J., Grimm L., et al. Commissioning and clinical implementation of a sliding gantry CT scanner installed in an existing treatment room and early clinical experience for precise tumor localization. Am J Clin Oncol 2003, 26:e28-e36.